MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell

[1]  Zhiwei Wang,et al.  MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell , 2014, BMC Cancer.

[2]  N. Allbritton,et al.  Isolation and in vitro culture of rare cancer stem cells from patient-derived xenografts of pancreatic ductal adenocarcinoma. , 2013, Analytical chemistry.

[3]  K. Yao,et al.  Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma , 2013, PloS one.

[4]  Jie Chen,et al.  Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation , 2013, Proceedings of the National Academy of Sciences.

[5]  J. Hoheisel,et al.  Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System , 2012, PloS one.

[6]  Kevin Struhl,et al.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state , 2012, Proceedings of the National Academy of Sciences.

[7]  Shadan Ali,et al.  Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. , 2012, Carcinogenesis.

[8]  S. Natsugoe,et al.  Epithelial–mesenchymal transition and mesenchymal–epithelial transition via regulation of ZEB‐1 and ZEB‐2 expression in pancreatic cancer , 2012, Journal of surgical oncology.

[9]  Xuanfu Xu,et al.  Down-Regulation of GEP100 Causes Increase in E-Cadherin Levels and Inhibits Pancreatic Cancer Cell Invasion , 2012, PloS one.

[10]  G. Packham,et al.  MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression , 2012, Biology of the cell.

[11]  S. Hanash,et al.  Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. , 2011, Cancer research.

[12]  Yuan-feng Tian,et al.  Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[13]  Gaetano Rocco,et al.  Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line , 2011, PloS one.

[14]  B. Bao,et al.  Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer , 2011, PloS one.

[15]  S. Shankar,et al.  Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition , 2011, PloS one.

[16]  S. Chiou,et al.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. , 2010, Cancer research.

[17]  B. Martín-Castillo,et al.  Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis , 2010, Cell cycle.

[18]  A. Rustgi,et al.  The role of the miR-200 family in epithelial-mesenchymal transition , 2010, Cancer biology & therapy.

[19]  S. Song,et al.  Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis , 2010, Pancreas.

[20]  A. Breiling,et al.  Nucleoside Drugs Induce Cellular Differentiation by Caspase-Dependent Degradation of Stem Cell Factors , 2010, PloS one.

[21]  M. Shackleton.  Normal stem cells and cancer stem cells: similar and different. , 2010, Seminars in cancer biology.

[22]  송시영,et al.  Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis , 2010 .

[23]  Zhiwei Wang,et al.  Pancreatic cancer stem cells and EMT in drug resistance and metastasis. , 2009, Minerva chirurgica.

[24]  O. Er,et al.  Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.

[25]  Zhihui Feng,et al.  A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. , 2009, Gynecologic oncology.

[26]  Zhiwei Wang,et al.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.

[27]  Zhiwei Wang,et al.  miR‐200 Regulates PDGF‐D‐Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells , 2009, Stem cells.

[28]  S. Kasper.  Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens. , 2009, Urologic oncology.

[29]  D. Radisky,et al.  Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. , 2009, Cancer research.

[30]  M. Nakao,et al.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. , 2009, The American journal of pathology.

[31]  K. Jauch,et al.  Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications , 2009, Langenbeck's Archives of Surgery.

[32]  P. Altevogt,et al.  Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling , 2008, Gut.

[33]  G. Goodall,et al.  The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition , 2008, TheScientificWorldJournal.

[34]  S. Chiou,et al.  Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma , 2008, Clinical Cancer Research.

[35]  B. Zhou,et al.  New insights of epithelial-mesenchymal transition in cancer metastasis. , 2008, Acta biochimica et biophysica Sinica.

[36]  Peng Huang,et al.  Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. , 2008, World journal of gastroenterology.

[37]  M. Korpal,et al.  The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.

[38]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[39]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[40]  A. Ben-Ze'ev,et al.  Epithelial-mesenchymal transition and the invasive potential of tumors. , 2008, Trends in molecular medicine.

[41]  G. Sommer,et al.  Reference , 2008 .

[42]  A. Karsan,et al.  Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. , 2007, The Journal of experimental medicine.

[43]  Laurie E Ailles,et al.  Cancer stem cells in solid tumors. , 2007, Current opinion in biotechnology.

[44]  Jing Zhou,et al.  Establishment of Clonal Colony-Forming Assay for Propagation of Pancreatic Cancer Cells With Stem Cell Properties , 2007, Pancreas.

[45]  J. Zavadil,et al.  TGF-beta and epithelial-to-mesenchymal transitions. , 2005, Oncogene.

[46]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[47]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[48]  A. Ben-Ze'ev.  The use of two‐dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors , 1996, Electrophoresis.